http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110669848-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af2dba654b452b10f03c95ee818fef3a |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-689 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-689 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
filingDate | 2018-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_938d38ccbd29ece92cad9935ef959555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5f4ee57b4dad2e9e2a21dd08ec8ee79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3fd1fff100ff4f44ca5e53b867fa307 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4767e83aba68d89ee6299a143b426fff |
publicationDate | 2020-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-110669848-A |
titleOfInvention | An artificial simulated molecular beacon and kit for the detection of Helicobacter pylori |
abstract | The invention discloses an artificial simulated molecular beacon and a kit for detecting Helicobacter pylori. The sequence of a molecular beacon for detecting Helicobacter pylori disclosed by the present invention is sequence 2 in the sequence table, and the molecular beacon satisfies: the second position of sequence 2 is a 5-methylisocytosine deoxynucleotide residue, the first The 6th position is an isoguanine deoxynucleotide residue, the 32nd position is a 5-methylisocytosine deoxynucleotide residue, the 36th position is an isoguanine deoxynucleotide residue, and the remaining cores of sequence 2 The nucleotide residues are all natural nucleotide residues. The molecular beacon and the method for detecting Hp disclosed by the invention have high sensitivity, fast detection speed, simple operation, objective interpretation of the results, less pollution of closed tube reaction, and are very suitable for large-scale clinical development. |
priorityDate | 2018-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 74.